Section 56, Assisted Reproductive Technology (Regulation) Act, 2021 [S2A-SBG]
As at 7 September 2026. In force from 12 May 2022 by S.O. 252(E) [N12-MJG].
56. Appeal.—(1) Any person aggrieved by an order of the Licensing Authority under this Act may, within thirty days from the date on which the order is communicated to him, prefer an appeal to the Drugs Controller in such form and accompanied by such fee as may be prescribed. (2) The appellate authority may, after giving the appellant an opportunity of being heard, confirm, modify or set aside the order appealed against. (3) No appeal shall lie under this section against an order made with the consent of the parties.
Defined terms in this text (2)
drug: Section 2, Assisted Reproductive Technology (Regulation) Act, 2021 [S2AQNM] (In this Act, unless the context otherwise requires,—): "drug" includes all medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals
drug: 19 more definitions.
Licensing Authority: Section 2, Assisted Reproductive Technology (Regulation) Act, 2021 [S2AQNM] (In this Act, unless the context otherwise requires,—): "Licensing Authority" means the authority appointed under section 4 to grant licences under this Act
Licensing Authority: 21 more definitions.
Made under this section, or naming it (0)
none
Cited by (1)
Section 59, Assisted Reproductive Technology (Regulation) Act, 2021 [S2A-SET], 19 November 2021, Band A. "section 56".
Not held (0)
none
Duties published under this section (0)
none